Significance levels in genome scans.

Area of Science:

• Genetics
• Genomics
• Complex Disease Research

Background:

• Genome-wide linkage scans are widely used for complex diseases like diabetes, multiple sclerosis, and schizophrenia.
• Progress in identifying disease-associated genes has been slow, with limited success in replication.

Purpose of the Study:

• To discuss the challenges in gene discovery for complex diseases.
• To explore the potential of genome-wide association studies (GWAS) in overcoming these challenges.
• To propose methods for addressing statistical significance and false positives in genetic scans.

Main Methods:

• Utilizes affected sibpair family data for genome-wide linkage scans.
• Incorporates PCR methodologies with pooled DNA samples and microsatellite variation for association studies.
• Highlights the use of single-nucleotide polymorphism (SNP) variation in recent GWAS.

Main Results:

• Complex diseases involve numerous genes, environmental factors, and their interactions, complicating gene identification.
• Genome-wide association studies are becoming feasible with advancements in molecular techniques.
• Challenges remain in achieving statistical significance and replicating linkage findings.

Conclusions:

• Locating genes for complex diseases is difficult due to polygenic inheritance and environmental interactions.
• Genome-wide association studies, particularly those using SNP variation, present a promising avenue for future research.
• Careful consideration of statistical significance and false positive rates is crucial for robust genetic findings.